Navigation Links
RAND finds cases of undiagnosed diabetes drop sharply
Date:8/13/2007

cases were considered as well, diabetes prevalence rose overall from 6 percent to 9 percent -- an increase of only 50 percent.

Diabetes is one of the major health challenges faced across the United States, but these findings suggest that the prevalence of the disease is not growing as rapidly as often claimed, Smith said.

The study examined reasons for the rising rate of diabetes over time. The three most important reasons by far were increases in excessive weight, the transmission of diabetes from parents to children as the disease spreads, and the decline in undiagnosed diabetes. In contrast, rising levels of education actually served to reduce the prevalence of the disease.

Smith examined information from several waves of the federal National Health and Nutrition Examination Surveys conducted periodically from 1976 to 2002. The survey collects information from a nationally representative sample of adults through personal interviews, physical exams and laboratory tests. Blood tests conducted as a part of the survey allow researchers to measure undiagnosed diabetes.

Among the men studied from 1999 to 2002, Smith found that 6 percent of those with a high school diploma or more education were diagnosed with diabetes, while nearly 10 percent of those who did not obtain a high school diploma were diagnosed with the disease.

Smith found that those in the lowest education group were more likely to be Latino or African-American, less likely to engage in vigorous physical exercise and more likely to be overweight or smoke cigarettes.

Even after diagnosis, people with less education had more difficulty successfully managing the complex regimes of medicines and making the lifestyle changes needed to reduce the consequences of the illness, according to the study.

Smith said one troubling finding from the study was that people who were obese were more likely to have undiagnosed diabetes, despite the fact that o
'/>"/>

Contact: RAND Office of Media Relations
media@rand.org
703-413-1100 x5117
RAND Corporation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Over Six Million HIV Infected People In South Africa- Finds A Survey
2. Its Never Too Late to Stop Smoking,Study Finds
3. Research finds new explanations for dyslexia
4. Poll Finds Many Americans Misinformed About Cancer
5. Poll Finds Many Americans Misinformed About Cancer
6. Research Finds How Post-traumatic Stress Leads to Long-Lasting Memories
7. Study Finds No Link Between Statins And Breast Cancer Risk
8. Survey finds that discussion with family very crucial in organ donation decision
9. Study finds no link between fibre and cancer risk
10. Study Finds Low Socio-Economic Status Linked to Poor Dental Health
11. Australian Court Finds Man Guilty of Spreading HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 2Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 3Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 4Health News:Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results 5Health News:JDRF and Lilly partner to fund research to identify beta cell biomarkers 2Health News:JDRF and Lilly partner to fund research to identify beta cell biomarkers 3Health News:Adult Type 2 Diabetes Can Be Predicted in Childhood 2Health News:Blue Cross and Blue Shield of Texas Announces Flexible, Affordable Blue MedicareRx(SM) Medicare Prescription Drug Plans 2Health News:New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves 2Health News:New Gallup Survey Finds Half of Los Angeles Area Residents Have Taken in a Near-Homeless Person, One-Third Fear Homelessness Themselves 3Health News:Pa. Department of Public Welfare Reminds New Parents About 'Safe Haven' Law 2
Breaking Medicine Technology:Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 1ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 2ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 3Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 1Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 1Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 3Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 4